IMIM - Institut Hospital del Mar d'Investigacions Mèdiques IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

News

12/05/2021 - General information

Dr. Clara Montagut to participate in the drafting of ESMO guidelines on the use of liquid biopsy in cancer patients

Montagut has been invited to be part of the group of experts who will draft the European Society of Medical Oncology recommendations on the appropriate use of this technique and its implementation in clinical practice.

The head of the Digestive Oncology section in the Medical Oncology Service at Hospital del Mar and researcher at the Hospital del Mar Medical Research Institute (IMIM), Dr. Clara Montagut, will be a co-author of the ESMO recommendations for the use of liquid biopsy in cancer patients. The project is led by Professor Nicholas Turner, from the Institute of Cancer Research in London. The initiative is one of the tasks of the organisation's Translational Research and Precision Medicine Working Group.

Developing these recommendations is part of this group's work to evaluate how useful the liquid biopsy technique is for stratifying oncology patients. For this reason, a study will be drafted including recommendations on when its use is appropriate in clinical practice and the most appropriate method for implementing it. This work is expected to be published before the end of the year in a scientific journal specialising in medical oncology.

More news

© Institut Hospital del Mar
d'Investigacions Mèdiques
Legal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact